[Continuous epidural administration of droperidol for the prevention of postoperative nausea].
Continuous antiemetic effect of epidural droperidol was evaluated by prospective, double-blinded study using 145 ASA physical status I-II patients undergoing major gynecological surgery. All patients received bolus epidural infusion of buprenorphine at the end of the operation and continuous epidural infusion of buprenorphine for 48 hours. Patients were divided into 3 groups, 49 patients of Group I received placebo, 50 patients of Group II received only bolus doses of droperidol 2.5 mg and the remaining 46 patients of Group III received continuous epidural infusion of droperidol 10 mg in 48 hours. Visual analogue scales for nausea, the incidence of emetic episodes and side effects were evaluated at 3 hr, 24 hr and 48 hr postoperatively. The scores for nausea were significantly lower in Group III (P < 0.05) compared with Group I 24 hr after the operation. The incidence of emesis was significantly lower in Group III (P < 0.05) as compared with Group I and II 48 hr after the operation. Extrapyramidal side effects and sedative effects were not observed in any patients. The continuous epidural administration of droperidol is effective in prevention of postoperative nausea and vomiting and the effect lasts during its infusion with no side effects.
Fukushima
Y
Y
Department of Anesthesiology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo 170-8476.
Satoh
M
M
Yasuda
S
S
Zenfuku
M
M
Shigematsu
T
T
D015360:Analgesia, Epidural; D000932:Antiemetics / Q000008:administration & dosage*; D004329:Droperidol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*
D000932:Antiemetics; D004329:Droperidol